antibacterial agents based cyclic dl-alpha-peptide architecture
rapid emergence bacterial infections resistant many drugs underscores need new therapeutic agents- report six eight-residue cyclic dl-alpha peptides act preferentially gram-positive and/or gram-negative bacterial membranes compared mammalian cells increase membrane permeability collapse transmembrane ion potentials cause rapid cell death effectiveness class materials selective antibacterial agents highlighted high efficacy observed lethal methicillin-resistant staphylococcus aureus infections mice cyclic dl-alpha peptides proteolytically stable easy synthesize can derived potentially vast membrane-active sequence space unique abiotic structure cyclic peptides quick bactericidal action may also contribute limit temporal acquirement drug resistant bacteria low molecular weight dl-alpha peptides offer attractive complement current arsenal naturally derived antibiotics hold considerable potential combating variety existing emerging infectious diseases
